Elemer Piros' Stock Ratings

Rodman & Renshaw Analyst

Elemer Piros is an analyst at Rodman & Renshaw. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/07/2024

Overall Average Return

2.80%

Smart Score

56%

Overall Average Return Percentile

44th

Number of Ratings

73
Buy NowGet Alert
07/02/2024CGTXBuy Now
Cognition Therapeutics
$1.95617.95%$14 → $14ReiteratesBuy → BuyGet Alert
07/02/2024ANVSBuy Now
Annovis Bio
$15.00346.67%$67 → $67ReiteratesBuy → BuyGet Alert
06/21/2024ANROBuy Now
Alto Neuroscience
$12.05256.85% → $43Initiates → BuyGet Alert
06/13/2024COYABuy Now
Coya Therapeutics
$5.95202.52% → $18Initiates → BuyGet Alert
09/14/2023HOTHBuy Now
Hoth Therapeutics
$0.95689.47%$12 → $7.5MaintainsBuyGet Alert
08/23/2023HOTHBuy Now
Hoth Therapeutics
$0.951373.68% → $14Assumes → BuyGet Alert
08/09/2023ATAIBuy Now
ATAI Life Sciences
$1.301053.85% → $15ReiteratesBuy → BuyGet Alert
08/09/2023COYABuy Now
Coya Therapeutics
$5.95370.59% → $28ReiteratesBuy → BuyGet Alert
08/04/2023MNMDBuy Now
Mind Medicine
$6.87205.68% → $21ReiteratesBuy → BuyGet Alert
08/03/2023CMPSBuy Now
Compass Pathways
$6.25508% → $38Reiterates → BuyGet Alert
07/28/2023DMTBuy Now
Small Pharma
→ $5ReiteratesBuy → BuyGet Alert
07/18/2023COYABuy Now
Coya Therapeutics
$5.95370.59% → $28ReiteratesBuy → BuyGet Alert
07/13/2023CMPSBuy Now
Compass Pathways
$6.25508% → $38ReiteratesBuy → BuyGet Alert
07/10/2023KTTABuy Now
Pasithea Therapeutics
$5.30-62.26% → $40ReiteratesBuy → BuyGet Alert
06/30/2023UNCYBuy Now
Unicycive Therapeutics
$0.46986.96% → $5ReiteratesBuy → BuyGet Alert
06/29/2023DMTBuy Now
Small Pharma
→ $5ReiteratesBuy → BuyGet Alert
06/20/2023ATAIBuy Now
ATAI Life Sciences
$1.301053.85% → $15ReiteratesBuy → BuyGet Alert
06/20/2023MNMDBuy Now
Mind Medicine
$6.87205.68% → $21ReiteratesBuy → BuyGet Alert
06/20/2023CYBNBuy Now
Cybin
→ $3ReiteratesBuy → BuyGet Alert
06/20/2023CMPSBuy Now
Compass Pathways
$6.25508% → $38ReiteratesBuy → BuyGet Alert
06/20/2023CLNNBuy Now
Clene
$0.352779.36%$13 → $10MaintainsBuyGet Alert
06/07/2023COYABuy Now
Coya Therapeutics
$5.95370.59% → $28ReiteratesBuy → BuyGet Alert
06/01/2023KTTABuy Now
Pasithea Therapeutics
$5.30-62.26% → $40Assumes → BuyGet Alert
06/01/2023HOTHBuy Now
Hoth Therapeutics
$0.951373.68% → $14Assumes → BuyGet Alert
05/30/2023CMPSBuy Now
Compass Pathways
$6.25508% → $38ReiteratesBuy → BuyGet Alert
05/25/2023DMTBuy Now
Small Pharma
→ $5ReiteratesBuy → BuyGet Alert
05/18/2023MNMDBuy Now
Mind Medicine
$6.87205.68% → $21ReiteratesBuy → BuyGet Alert
05/17/2023UNCYBuy Now
Unicycive Therapeutics
$0.46986.96% → $5ReiteratesBuy → BuyGet Alert
05/16/2023COYABuy Now
Coya Therapeutics
$5.95370.59% → $28ReiteratesBuy → BuyGet Alert
05/16/2023OPTBuy Now
Opthea
$1.951079.49% → $23ReiteratesBuy → BuyGet Alert
05/11/2023CMPSBuy Now
Compass Pathways
$6.25508% → $38ReiteratesBuy → BuyGet Alert
05/10/2023COYABuy Now
Coya Therapeutics
$5.95370.59% → $28ReiteratesBuy → BuyGet Alert
05/05/2023MNMDBuy Now
Mind Medicine
$6.87205.68% → $21Reiterates → BuyGet Alert
05/03/2023COYABuy Now
Coya Therapeutics
$5.95370.59% → $28Initiates → BuyGet Alert
04/17/2023OPTBuy Now
Opthea
$1.951079.49% → $23Initiates → BuyGet Alert
04/14/2023MNMDBuy Now
Mind Medicine
$6.87205.68% → $21Reiterates → BuyGet Alert
04/12/2023CMPSBuy Now
Compass Pathways
$6.25508% → $38Reiterates → BuyGet Alert
04/10/2023DMTBuy Now
Small Pharma
→ $5Reiterates → BuyGet Alert
03/31/2023ATAIBuy Now
ATAI Life Sciences
$1.301053.85% → $15Reiterates → BuyGet Alert
03/31/2023UNCYBuy Now
Unicycive Therapeutics
$0.465117.39% → $24Reiterates → BuyGet Alert
03/28/2023MNPRBuy Now
Monopar Therapeutics
$0.732216.08%$24 → $17MaintainsBuyGet Alert
03/27/2023ATAIBuy Now
ATAI Life Sciences
$1.301053.85% → $15Reiterates → BuyGet Alert
03/24/2023MNPRBuy Now
Monopar Therapeutics
$0.733169.75% → $24Reiterates → BuyGet Alert
03/23/2023CLNNBuy Now
Clene
$0.353643.16% → $13Reiterates → BuyGet Alert
03/13/2023CLNNBuy Now
Clene
$0.353643.16% → $13Reiterates → BuyGet Alert
03/10/2023MNMDBuy Now
Mind Medicine
$6.87205.68% → $21Reiterates → BuyGet Alert
03/09/2023CLNNBuy Now
Clene
$0.353643.16% → $13Reiterates → BuyGet Alert
03/09/2023UNCYBuy Now
Unicycive Therapeutics
$0.46986.96% → $5Initiates → BuyGet Alert
03/08/2023CLNNBuy Now
Clene
$0.353643.16% → $13Initiates → BuyGet Alert
03/07/2023ATAIBuy Now
ATAI Life Sciences
$1.301053.85% → $15Reiterates → BuyGet Alert
03/07/2023DMTBuy Now
Small Pharma
→ $5Reiterates → BuyGet Alert
03/02/2023GHRSBuy Now
GH Research
$11.75180.85% → $33Reiterates → BuyGet Alert
02/28/2023CMPSBuy Now
Compass Pathways
$6.25508% → $38Reiterates → BuyGet Alert
02/14/2023CYBNBuy Now
Cybin
→ $3Reiterates → BuyGet Alert
02/14/2023REUNBuy Now
Reunion Neuroscience
→ $11Reiterates → BuyGet Alert
02/14/2023MNPRBuy Now
Monopar Therapeutics
$0.733169.75% → $24Reiterates → BuyGet Alert
01/25/2023DMTBuy Now
Small Pharma
$2.5 → $5Reiterates → BuyGet Alert
01/23/2023MNPRBuy Now
Monopar Therapeutics
$0.733169.75% → $24Initiates → BuyGet Alert
01/06/2023ATAIBuy Now
ATAI Life Sciences
$1.301053.85%$23 → $15MaintainsBuyGet Alert
12/16/2022ATAIBuy Now
ATAI Life Sciences
$1.301669.23% → $23Initiates → BuyGet Alert
12/16/2022GHRSBuy Now
GH Research
$11.75180.85% → $33Initiates → BuyGet Alert
12/16/2022CMPSBuy Now
Compass Pathways
$6.25508% → $38Initiates → BuyGet Alert
12/16/2022MNMDBuy Now
Mind Medicine
$6.87205.68% → $21Initiates → BuyGet Alert
12/16/2022CYBNBuy Now
Cybin
→ $3Initiates → BuyGet Alert
12/16/2022DMTBuy Now
Small Pharma
→ $2.5Initiates → BuyGet Alert
12/16/2022REUNBuy Now
Reunion Neuroscience
→ $11Initiates → BuyGet Alert
06/16/2022GHRSBuy Now
GH Research
$11.75461.7% → $66Initiates → BuyGet Alert
05/04/2022MNMDBuy Now
Mind Medicine
$6.871.89% → $105Initiates → BuyGet Alert
04/14/2022APLSBuy Now
Apellis Pharmaceuticals
$37.117.79% → $40DowngradeNeutral → SellGet Alert
01/04/2022UBXBuy Now
Unity Biotechnology
$1.34198.51% → $40UpgradeNeutral → BuyGet Alert
12/01/2021BRTXBuy Now
BioRestorative Therapies
$1.921827.08%Initiates → BuyGet Alert
11/29/2021APLSBuy Now
Apellis Pharmaceuticals
$37.117.79%DowngradeBuy → NeutralGet Alert
11/11/2021ATAIBuy Now
ATAI Life Sciences
$1.302361.54%Initiates → BuyGet Alert